Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 28Unknown 6Terminated 4Not yet recruiting 3Withdrawn 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 4Adenocarcinoma 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Pancreaticoduodenectomy × Clear all
NCT03531125 2020-03-25

NEOPANC-01

University of Oxford

Terminated
9 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01240304 2019-12-10

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

University of Arkansas

Phase 2 Terminated
10 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00766636 2016-05-19

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01419002 2015-07-29

Net-Pac

CHIR-Net

Phase 3 Terminated
5 enrolled
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡